A patient with atypical partial lipodystrophy who had a transient initial response to metreleptin experienced acute worsening of her metabolic state when neutralizing antibodies against metreleptin appeared. Because her metabolic status continued to deteriorate. a therapeutic trial with melanocortin-4 receptor agonist setmelanotide. that is believed to function downstream from leptin ... https://macorners.shop/product-category/magnet/